Safety of Tazobactam During Pregnancy

Safety Profile

• Piperacillin/tazobactam is classified as pregnancy category B1 (Australian classification) or B (FDA classification), indicating it is considered low risk in pregnancy 1, 2
• In humans, no cases of congenital defects have been reported with piperacillin/tazobactam use during pregnancy 1

Clinical Evidence and Recommendations

• The European Respiratory Society/TSANZ task force statement explicitly lists piperacillin/tazobactam as "compatible" for use during pre-conception and first trimester 1, 2
• All penicillins, including piperacillin/tazobactam, are generally considered low risk in pregnancy based on decades of clinical experience 1

Pharmacokinetic Considerations

• Piperacillin/tazobactam does cross the placenta and is present in breast milk 1
• The drug has low oral bioavailability, although in premature infants and neonates there may be increased intestinal absorption 1

Clinical Decision Making

• For severe infections requiring broad-spectrum coverage, piperacillin/tazobactam is a safer choice compared to other broad-spectrum alternatives such as aminoglycosides, which should be avoided if possible during pregnancy 1

Piperacillin-Tazobactam Safety in Pregnancy

Alternative Antibiotics

• The American College of Physicians, as reported by the Mayo Clinic Proceedings, recommends ceftriaxone plus metronidazole as a safe alternative for broad-spectrum coverage of gram-positive, gram-negative, and anaerobic bacteria during pregnancy 3
• The Mayo Clinic Proceedings suggests ertapenem as a carbapenem alternative with a favorable safety profile during pregnancy 3